Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Haibel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|August 12, 2006
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trialH Haibel, H C Brandt, I H Song, et al.
Zeitschrift Fur Rheumatologie|June 8, 2019
[Health care and disease burden in persons with axial spondyloarthritis in Germany]H Haibel, I Redeker, A Zink, et al.
Arthritis and Rheumatism|June 17, 2000
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximabJ Brandt, H Haibel, D Cornely, et al.
Arthritis and Rheumatism|June 10, 2003
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitisJ Brandt, A Khariouzov, J Listing, et al.
Arthritis and Rheumatism|May 2, 2007
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agentsJ Braun, X Baraliakos, J Listing, et al.
RMD Open|January 6, 2025
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapyMurat Torgutalp, Judith Rademacher, Fabian Proft, et al.
Zeitschrift Fur Rheumatologie|April 15, 2018
[Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases]H-G Schaible, H-D Chang, S Grässel, et al.
Annals of the Rheumatic Diseases|May 10, 2011
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48I-H Song, K G Hermann, H Haibel, et al.
Annals of the Rheumatic Diseases|March 5, 2011
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialI-H Song, Kg Hermann, H Haibel, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|August 12, 2006
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trialH Haibel, H C Brandt, I H Song, et al.
Zeitschrift Fur Rheumatologie|June 8, 2019
[Health care and disease burden in persons with axial spondyloarthritis in Germany]H Haibel, I Redeker, A Zink, et al.
Arthritis and Rheumatism|June 17, 2000
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximabJ Brandt, H Haibel, D Cornely, et al.
Arthritis and Rheumatism|June 10, 2003
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitisJ Brandt, A Khariouzov, J Listing, et al.
Arthritis and Rheumatism|May 2, 2007
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agentsJ Braun, X Baraliakos, J Listing, et al.
RMD Open|January 6, 2025
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapyMurat Torgutalp, Judith Rademacher, Fabian Proft, et al.
Zeitschrift Fur Rheumatologie|April 15, 2018
[Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases]H-G Schaible, H-D Chang, S Grässel, et al.
Annals of the Rheumatic Diseases|May 10, 2011
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48I-H Song, K G Hermann, H Haibel, et al.
Annals of the Rheumatic Diseases|March 5, 2011
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialI-H Song, Kg Hermann, H Haibel, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Pageof 4